$4,799.54 travel Payment -- Takeda Pharmaceuticals to Dr. Joseph Carter
Takeda Pharmaceuticals covers $4,799.54 in travel and lodging for Gastroenterologist Joseph Carter.
This page provides a detailed analysis of a $4,799.54 travel payment from Takeda Pharmaceuticals to Dr. Joseph Carter. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $4,799.54 |
| Payment Type | travel |
| Payment Nature | Travel and Lodging |
| Pharmaceutical Company | Takeda Pharmaceuticals |
| Physician | Dr. Joseph Carter |
| NPI Number | 1405219310 |
| Physician Specialty | Gastroenterology |
| Location | Philadelphia, PA |
| Date of Payment | 2025-05-29 |
| Conflict Assessment | Moderate -- Worth Noting |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Takeda Pharmaceuticals made a $4.8K travel payment to Joseph Carter, a Gastroenterology specialist in Philadelphia, PA. The payment of $4,799.54 to Dr. Joseph Carter from Takeda Pharmaceuticals in May 2025 was for travel and lodging. This payment represents a significant travel expense for a single physician, potentially covering multiple trips or extended stays. The nature of the payment, 'Travel and Lodging,' suggests it may be related to conferences, educational events, or consultations.
Patient Guidance: What This Payment Means for You
This payment was for travel and lodging expenses incurred by your physician, which may be related to professional development or educational activities. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
While travel and lodging payments are common in Gastroenterology, the amount of $4,799.54 is on the higher end and warrants review for appropriateness relative to industry standards for similar events.
Regulatory Context: Sunshine Act Requirements
Payments for travel and lodging must be reported under the Sunshine Act if they are made by applicable manufacturers to physicians and are not excluded items.
Related Topics
This payment is related to the following healthcare transparency topics:
- pharmaceutical-payments
- physician-compensation
- travel-expenses
- gastroenterology
- cms-open-payments
- takeda-pharmaceuticals
Understanding travel Payments
Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.
Frequently Asked Questions About This Payment
What was this $4.8K payment for?
This was a travel payment of $4.8K from Takeda Pharmaceuticals to Joseph Carter, categorized as "Travel and Lodging". The payment was reported under the Sunshine Act (CMS Open Payments).
Does Joseph Carter accept pharmaceutical money?
Yes, Joseph Carter received this $4.8K payment from Takeda Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Joseph Carter's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this travel payment?
A travel payment of $4.8K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Gastroenterology?
To compare this payment against Gastroenterology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Gastroenterology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Joseph Carter's relationship with Takeda Pharmaceuticals?
The payment amount is substantial for travel and lodging, exceeding typical per-diem rates for many conferences. This $4.8K travel payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Gastroenterology?
The specific purpose of the travel and lodging is not detailed in this record.
What should patients do after learning about this payment?
This payment was for travel and lodging expenses incurred by your physician, which may be related to professional development or educational activities.
What else should I know about this travel payment?
The payment was made by Takeda Pharmaceuticals, a company with a significant presence in the pharmaceutical industry.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.